Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
None listed
Sponsors
Jawaharlal Nehru Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients having age 18 years and above with type 2 DM on SGLT2 inhibitors and/ or on other oral antidiabetics
Exclusion criteria
Exclusion criteria: Type 1 Diabetes Mellitus Patients on insulin or other injectable agents Patients on systemic corticosteroids and other drugs which may affect the glycaemic parameters History of Diabetic Ketoacidosis (DKA) Significant Diabetic nephropathy Patients with significant liver disease Congestive Heart Failure (CHF) Patients with significant lung disease Septicaemia Psychotic patient Pregnancy Known cases of HIV / HBsAg / Anti-HCV and immunocompromised patients Any other severe systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimation of HbA1c Fasting Plasma Glucose (FPG) 2Hour Plasma Glucose (2HPG)Timepoint: HbA1c at Baseline, 12 weeks and 24 weeks FPG and 2HPG at baseline, 6 weeks, 12 weeks, 18 weeks and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in HbA1C from baseline values. Effects of SGLT2 inhibitors on Renal system, cardiovascular systemTimepoint: 12 weeks and 24 weeks | — |
Countries
India
Contacts
Public ContactMohammad Zeeshan
Aligarh Muslim University
Outcome results
None listed